Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
RAC Announcements
CPACS Trial Cleared to Escalate to Next…
RAC
RACURA ONCOLOGY LTD
Market sensitive
CPACS Trial Cleared to Escalate to Next RC220 Dose Level
Date and time
15 May 2026 at 7:04 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
RAC announcement history
Recent RAC announcements
Racure Oncology Techknow Invest Presentation
First HARNESS-1 Patient Safely Treated with RC220
June 2026 Quarterly Activities Report and Appendix 4C
Notification of cessation of securities - RAC
Racura to Present CPACS Data at GCOS 2026
Racura Oncology New Zealand Investor Events